Company has outstanding debt obligations for the first time in last 5 years. (Source: Standalone Financials)
Pharmaids Pharmaceuticals Share Price
Pharmaids Pharmaceutica...
Pharmaids Pharm share price insights
Company has posted a loss of Rs 2.68 cr for the 4th consecutive quarter. (Source: Consolidated Financials)
Stock gave a 3 year return of 215.41% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)
Company has spent 10.38% of its operating revenues towards interest expenses and 60.85% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Pharmaids Pharmaceuticals Ltd. share price moved down by -1.95% from its previous close of Rs 43.92. Pharmaids Pharmaceuticals Ltd. stock last traded price is 43.06
Share Price Value Today/Current/Last 43.06 Previous Day 43.92
Key Metrics
PE Ratio (x) | -14.68 | ||||||||||
EPS - TTM (₹) | -2.93 | ||||||||||
MCap (₹ Cr.) | 151.86 | ||||||||||
Sectoral MCap Rank | 122 | ||||||||||
PB Ratio (x) | 2.21 | ||||||||||
Div Yield (%) | 0.00 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| 0.00 | ||||||||||
VWAP (₹) | 44.11 | ||||||||||
52W H/L (₹) |
Pharmaids Pharm Share Price Returns
1 Day | -1.95% |
1 Week | -0.99% |
1 Month | -3.93% |
3 Months | -20.33% |
1 Year | 13.14% |
3 Years | 181.44% |
5 Years | N.A. |
Pharmaids Pharm News & Analysis
Pharmaids Pharm Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Pharmaids Pharm Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Insights
PAT: Troublesome Times
Company has posted a loss of Rs 2.68 cr for the 4th consecutive quarter. (Source: Consolidated Financials)Employee & Interest Expense
Company has spent 10.38% of its operating revenues towards interest expenses and 60.85% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Quarterly | Annual Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Total Income 4.68 5.93 -0.88 -0.26 0.37 Total Income Growth (%) -20.95 -773.14 241.51 -169.27 - Total Expenses 8.72 12.02 1.33 1.03 1.58 Total Expenses Growth (%) -27.41 803.69 29.17 -34.75 -81.66 EBIT -4.04 -6.09 -2.21 -1.29 -1.21 EBIT Growth (%) - - - - - Profit after Tax (PAT) -2.68 -5.52 -1.63 -0.50 -1.30 PAT Growth (%) - - - - - EBIT Margin (%) -86.25 -102.82 251.08 499.42 -324.02 Net Profit Margin (%) -57.31 -93.16 185.68 195.71 -349.47 Basic EPS (₹) -0.76 -2.82 -0.76 -0.24 -0.61 All figures in Rs Cr, unless mentioned otherwise
Insights
Undertaking New Debt
Company has outstanding debt obligations for the first time in last 5 years. (Source: Standalone Financials)
Annual FY 2024 FY 2023 Total Assets 91.34 24.59 Total Assets Growth (%) 271.50 121.26 Total Liabilities 20.84 - Total Liabilities Growth (%) - - Total Equity 70.50 22.46 Total Equity Growth (%) 213.88 159.01 Current Ratio (x) 1.17 8.23 Total Debt to Equity (x) 0.07 0.00 Contingent Liabilities 0.00 - All figures in Rs Cr, unless mentioned otherwise
Insights
Increase in Cash from Investing
Company has used Rs 74.99 cr for investing activities which is an YoY increase of 1417.01%. (Source: Consolidated Financials)
Annual FY 2024 FY 2023 Net Cash flow from Operating Activities -10.62 -4.02 Net Cash used in Investing Activities -74.99 -4.94 Net Cash flow from Financing Activities 77.66 21.31 Net Cash Flow -7.95 12.35 Closing Cash & Cash Equivalent 4.80 12.75 Closing Cash & Cash Equivalent Growth (%) -62.33 3,030.27 Total Debt/ CFO (x) -0.50 0.00 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 Return on Equity (%) -11.05 -33.64 Return on Capital Employed (%) -17.61 -44.09 Return on Assets (%) -8.72 -30.72 Interest Coverage Ratio (x) -7.86 -2,135.71 Asset Turnover Ratio (x) 0.26 - Price to Earnings (x) -23.04 -6.19 Price to Book (x) 2.55 2.08 EV/EBITDA (x) -14.79 -3.44 EBITDA Margin (%) -81.57 0.00
Pharmaids Pharm Peer Comparison
Pharmaids Pharm Stock Performance
Ratio Performance
Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 215.41% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated 215.41% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)
Choose from Peers
Choose from Stocks
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 215.41% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated 215.41% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)
See All Parameters
MF Ownership
MF Ownership details are not available.
Corporate Actions
Pharmaids Pharm Board Meeting/AGM
Pharmaids Pharm Dividends
- Others
Meeting Date Announced on Purpose Details May 28, 2024 May 21, 2024 Board Meeting Audited Results Feb 12, 2024 Feb 02, 2024 Board Meeting Quarterly Results Jan 31, 2024 Jan 08, 2024 EGM - Jan 06, 2024 Jan 03, 2024 Board Meeting Preferential issue of shares Nov 11, 2023 Nov 06, 2023 Board Meeting Quarterly Results Dividend announcements are not available.
No other corporate actions details are available.
About Pharmaids Pharm
Executives
Auditors
- MM
Mini Manikantan
Executive DirectorVMVenu Madhava Kaparthy
Executive DirectorVRVenkata Rao Sadhanala
Non Exe.Non Ind.DirectorMNMethuku Nagesh
Independent DirectorShow More - PPKG & Co.Rakesh S Jain & Associates
Industry
Key Indices Listed on
-
Address
Unit 201,, Brigade Rubix, 2nd Floor,20/14, HMT Factory Main Road,Peenya Plantation,Bengaluru, Karnataka - 560013
More Details
Trending in Markets
Pharmaids Pharm Quick Links
Equity Quick Links
More from Markets
IPOStock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.